A further AGM update on Medibank Private's cyber crime woes revealed no further suspicious activity since October 12, notesMorgan Stanley, while associated non-recurring costs are still estimated to be around -$25-35m, 

Management that in the year-to-November 12, policyholder growth was 14,500, showing only a small decline since the cyber crime commenced.

The broker retains its Equal-weight rating and $3.05 target. Industry View: In-line.

Sector: Insurance.

Target price is $3.05.Current Price is $2.79. Difference: $0.26 - (brackets indicate current price is over target). If MPL meets the Morgan Stanley target it will return approximately 9% (excluding dividends, fees and charges - negative figures indicate an expected loss).

© 2022 Acquisdata Pty Ltd., source FN Arena